[Not Available].
作者信息
Wu Peter E, Morris Andrew M
机构信息
Département de médecine (Wu, Morris), Division de pharmacologie et de toxicologie clinique (Wu) et Division d'infectiologie (Morris), Université de Toronto; Division de médecine interne générale et de gériatrie (Wu), Réseau universitaire de santé; Division d'infectiologie (Morris), Système de santé Sinai et Réseau universitaire de santé, Toronto, Ont.
出版信息
CMAJ. 2021 Apr 6;193(14):E495-E496. doi: 10.1503/cmaj.202505-f.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]。
CMAJ. 2021 Apr 6;193(14):E495-E496. doi: 10.1503/cmaj.202505-f.
2
Remdesivir for patients with COVID-19.瑞德西韦用于治疗新冠肺炎患者。
CMAJ. 2021 Jan 25;193(4):E125. doi: 10.1503/cmaj.202505. Epub 2021 Jan 6.
3
COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.2019冠状病毒病最新情况：瑞德西韦（Veklury）用于高危2019冠状病毒病门诊患者。
Med Lett Drugs Ther. 2022 Feb 21;64(1644):31-32.
4
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).瑞德西韦是否应用于治疗 COVID-19 患者？美国医师学会的快速实践要点（第 1 版）。
Ann Intern Med. 2021 Feb;174(2):229-236. doi: 10.7326/M20-5831. Epub 2020 Oct 5.
5
Remdesivir as a broad-spectrum antiviral drug against COVID-19.瑞德西韦作为一种广谱抗 COVID-19 病毒药物。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):541-548. doi: 10.26355/eurrev_202101_24426.
6
Safety profile of the antiviral drug remdesivir: An update.抗病毒药物瑞德西韦的安全性概况：最新情况
Biomed Pharmacother. 2020 Oct;130:110532. doi: 10.1016/j.biopha.2020.110532. Epub 2020 Jul 22.
7
Remdesivir for the treatment of COVID-19 in pregnancy.瑞德西韦用于治疗妊娠期新型冠状病毒肺炎
J Med Virol. 2021 Jul;93(7):4114-4119. doi: 10.1002/jmv.26986. Epub 2021 Apr 14.
8
Missed Opportunities on Emergency Remdesivir Use.瑞德西韦紧急使用中的错失机会
JAMA. 2020 Jul 28;324(4):331-332. doi: 10.1001/jama.2020.11932.
9
Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19.瑞德西韦和法匹拉韦治疗 COVID-19 的心血管注意事项。
Cardiovasc Hematol Disord Drug Targets. 2021;21(2):88-90. doi: 10.2174/1871529X21666210812103535.
10
Audio Interview: New Data on Remdesivir in Covid-19.音频访谈：瑞德西韦治疗新冠病毒病的新数据
N Engl J Med. 2020 May 28;382(22):e94. doi: 10.1056/NEJMe2019975.
本文引用的文献
1
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
2
Acetylcysteine for the Treatment of Suspected Remdesivir-Associated Acute Liver Failure in COVID-19: A Case Series.乙酰半胱氨酸治疗 COVID-19 瑞德西韦相关急性肝衰竭：病例系列。
Pharmacotherapy. 2020 Nov;40(11):1166-1171. doi: 10.1002/phar.2464. Epub 2020 Oct 27.
3
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.瑞德西韦对比标准治疗对 11 天内中症 COVID-19 患者临床状态的影响：一项随机临床试验。
JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.
4
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
5
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
Zotero 插件